Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $284.27 +0.06%
EPS Growth %: -24.9%
Financial Fact:
Other, net: 1.22M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -24.9%
Financial Fact:
Other, net: 1.22M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q1 EPS of $0.35, $0.10 better than the analyst estimate of $0.25. Revenue for the quarter came in at $16 million versus the consensus estimate of $13.63 million.
For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- GitLab’s second-quarter revenue jumps 21% as AI demand drives bookings
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
